课题基金 / 基金详情

Development the efficacious pharmacotherapy based on PK/PD/PGx analyses in patients with rheumatoid arthritis

Development the efficacious pharmacotherapy based on PK/PD/PGx analyses in patients with rheumatoid arthritis
基于 PK/PD/PGx 分析开发类风湿关节炎患者的有效药物疗法
批准号:
22790164
负责人:
HAYASHI Hideki
金额:
$2.25万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2011

项目摘要

项目成果

HAYASHI Hideki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A patient's responsiveness to methotrexate(MTX) for treating rheumatoid arthritis(RA) has the individual differences. The present study examined genetic polymorphisms related to folate metabolism pathway and concentrations of MTX and its active form, MTX. polyglutamates(MTX. PGs), in red blood cells(RBCs) in RA patients. The patients with the G allele of the G80A polymorphism of the folate transporter gene RFC1 had less intracellular MTX uptake and therefore had poor efficacy ; a greater number of them were found to be biological preparations concomitant cases. The results of the present study suggest the possibility that the RFC1 G80A polymorphism and MTX. PGs levels in patients' RBCs may be a useful marker for predicting MTX efficacy in Japanese patients with RA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
An artifact derived from a pseudogene led to the discovery of microRNA binding site polymorphism in the 3'-untranslated region of the human dihydrofolate reductase gene
源自假基因的人工产物导致人类二氢叶酸还原酶基因 3-非翻译区中 microRNA 结合位点多态性的发现
DOI: --
发表时间: 2012
期刊: Drug Metab. Pharmacokinet
影响因子: --
作者: [Hayashi H, Tazoe Y, Horino M, Fujimaki-Katoh C, Tsuboi S, Matsuyama T, Kosuge K, Yamada H, Tsuji D, Inoue K, Itoh K]
通讯作者: Itoh K
関節リウマチでのメトトレキサート療法に影響する遺伝的因子の解析
影响甲氨蝶呤治疗类风湿性关节炎的遗传因素分析
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [田添唯、林秀樹, ほか]
通讯作者: ほか
抗リウマチ薬メトトレキサートの赤血球中濃度と遺伝子多型の関連性の検討
抗风湿药甲氨蝶呤红细胞浓度与基因多态性关系的研究
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [田添唯, 林秀樹, 森下茉莉子, 坪井声示, 松山耐至, 荒井輝久, 大鹿雄美, 小菅和仁, 山田浩, 辻大樹, 井上和幸, 伊藤邦彦]
通讯作者: 伊藤邦彦
DOI: 10.2133/dmpk.dmpk-10-sc-036
发表时间: 2010-01-01
期刊: DRUG METABOLISM AND PHARMACOKINETICS
影响因子: 2.1
作者: [Hayashi, Hideki, Horino, Masato, Itoh, Kunihiko]
通讯作者: Itoh, Kunihiko
9
    Development of gene therapy using self-destructive lentivirus vectors
    • 批准号:
      16K15319
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2016
    • 负责人:
      HAYASHI Hideki
    • 依托单位:
    Fundamental analyses of our near-infrared fluorescent liposome system as therapeutic agents against gastrointestinal malignancies
    • 批准号:
      24591933
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      HAYASHI Hideki
    • 依托单位:
    Defensive mechanism of interferon-regulatory factors (IRFs) via trypsinogens against virus infection.
    • 批准号:
      24590555
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.49万
    • 财政年份:
      2012
    • 负责人:
      HAYASHI Hideki
    • 依托单位:
    A potential treatment of glaucoma by glia-derived lipoproteins.
    • 批准号:
      22790254
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.58万
    • 财政年份:
      2010
    • 负责人:
      HAYASHI Hideki
    • 依托单位:
    海外基金